Aa
Sign petition to put pressure on!
A petition was begun to encourage Gilead to do the right thing. Please sign it:
http://www.change.org/petitions/gilead-sciences-a-phase-iii-collaboration-for-the-treatment-of-hepatitis-c
I have emailed this link to all my family and friends and posted it on FB. Lets make ourselves heard! Who knows...this might be the spark needed to start the fire!
http://www.change.org/petitions/gilead-sciences-a-phase-iii-collaboration-for-the-treatment-of-hepatitis-c
I have emailed this link to all my family and friends and posted it on FB. Lets make ourselves heard! Who knows...this might be the spark needed to start the fire!
Oh yeah I dont care how many time people see the post to sign the petition its up to us to make it HAPPEN were not only victims were the CURE and HOPE for other people in the future lets make this worth it people! I am not this sick for nothing--- good is going to come out of it. when I am well I am interviewing some of you if you want and making a true video for You Tube it will be our stories what we went through it will get heard I promise you that.
"I saw it too. My guess is medhelp pulled it as a duplicate. '
======================================
Here it is, I think:
http://www.medhelp.org/posts/Hepatitis-Social/Does-Gilead-hold-the-key-to-CURE/show/1726970#post_7919161
======================================
Here it is, I think:
http://www.medhelp.org/posts/Hepatitis-Social/Does-Gilead-hold-the-key-to-CURE/show/1726970#post_7919161
I saw this today, just to provide a little more current info. It appears that BMS is still trying to further the collaboration;
http://www.natap.org/2012/HCV/060112_05.htm
(visit the above link for the compete story-willy)
"By Ransdell Pierson
Thu May 31, 2012
(Reuters) - Bristol-Myers Squibb Co renewed calls for biotechnology company Gilead Sciences Inc to test one of its hepatitis C drugs in late-stage trials alongside Bristol's own promising medicine, following impressive results from a mid-stage trial that combined the experimental products.
Bristol's daclatasvir is from a new class of drugs known as NS5A inhibitors. Gilead's GS-7977 is a nucleotide polymerase inhibitor. Both are designed to block enzymes essential to replication of the hepatitis C virus.
Bristol-Myers Chief Executive Lamberto Andreotti, speaking on Thursday at the Sanford Bernstein Strategic Decisions Conference in New York, said patients and both drugmakers stand to benefit if combined Phase III trials of the two medicines are pursued.
"We have a different point of view about whether to enter Phase III (trials) with that combination," Andreotti said. "We believe, for both patients and companies, it is better to move forward" in the short term.
But Andreotti said Gilead instead seemed intent on looking "in-house" -- focusing on combinations of its own products. Gilead officials could not immediately be reached to comment."
=====================
You'll note that this thread is about 8 weeks old and there is still no word on starting any sort of trial. It is possible that if Gilead had intended to continue the collaboration that they could have started a phase 3 trial 2-3- or even 4 months ago.
Every month that goes by without a trial in progress may be equated with unnecessary mortality, since this combination of drugs seems to be effective on more advanced cirrhotics than triple therapy, may provide a safer treatment, a more effective treatment, and a treatment which appears to work on close to virtually all who have participated so far.
willy
http://www.natap.org/2012/HCV/060112_05.htm
(visit the above link for the compete story-willy)
"By Ransdell Pierson
Thu May 31, 2012
(Reuters) - Bristol-Myers Squibb Co renewed calls for biotechnology company Gilead Sciences Inc to test one of its hepatitis C drugs in late-stage trials alongside Bristol's own promising medicine, following impressive results from a mid-stage trial that combined the experimental products.
Bristol's daclatasvir is from a new class of drugs known as NS5A inhibitors. Gilead's GS-7977 is a nucleotide polymerase inhibitor. Both are designed to block enzymes essential to replication of the hepatitis C virus.
Bristol-Myers Chief Executive Lamberto Andreotti, speaking on Thursday at the Sanford Bernstein Strategic Decisions Conference in New York, said patients and both drugmakers stand to benefit if combined Phase III trials of the two medicines are pursued.
"We have a different point of view about whether to enter Phase III (trials) with that combination," Andreotti said. "We believe, for both patients and companies, it is better to move forward" in the short term.
But Andreotti said Gilead instead seemed intent on looking "in-house" -- focusing on combinations of its own products. Gilead officials could not immediately be reached to comment."
=====================
You'll note that this thread is about 8 weeks old and there is still no word on starting any sort of trial. It is possible that if Gilead had intended to continue the collaboration that they could have started a phase 3 trial 2-3- or even 4 months ago.
Every month that goes by without a trial in progress may be equated with unnecessary mortality, since this combination of drugs seems to be effective on more advanced cirrhotics than triple therapy, may provide a safer treatment, a more effective treatment, and a treatment which appears to work on close to virtually all who have participated so far.
willy
This will have to go viral to succeed. Mdud -cudos for your passion and hard work. Tiredofhepc- thank you for your utilization of your contacts.
What can we do that is unique and will spark interest? Time to brainstorm everyone, all the great talent and minds here should be able to come up with some plausible ideas. Remember the first rule of brainstorming is no idea is a dumb idea.
Our goal is to get Gilead to listen to the masses, that is politics and if we can accomplish this phase - gt their attention- then they will be more likely to respond in a socially responsible manner. Social irresponsibility is an intangible asset that all corporations crave. inexpensive goodwill. We have to make them want to be the hero in this fight not the villain.
Lets start posting ideas on how to get to the next step, formulate plan, strategize, implement and execute. We have the knowledge, talent and power. LETS GO START THE BRAINSTORM. Emergent leaders, lets unite!!
What can we do that is unique and will spark interest? Time to brainstorm everyone, all the great talent and minds here should be able to come up with some plausible ideas. Remember the first rule of brainstorming is no idea is a dumb idea.
Our goal is to get Gilead to listen to the masses, that is politics and if we can accomplish this phase - gt their attention- then they will be more likely to respond in a socially responsible manner. Social irresponsibility is an intangible asset that all corporations crave. inexpensive goodwill. We have to make them want to be the hero in this fight not the villain.
Lets start posting ideas on how to get to the next step, formulate plan, strategize, implement and execute. We have the knowledge, talent and power. LETS GO START THE BRAINSTORM. Emergent leaders, lets unite!!
I saw it too. My guess is medhelp pulled it as a duplicate.
They do that sometimes.
They do that sometimes.
Maybe I have been out in the sun too long, but I was sure you had a new thread about the petition that I replied to. I stated that I had re posted the link on my FB page with a personal note about my having Hep. C, hoping to encourage those folks who hadn't bothered with it the first time.
I usually ignore posts and polls that come to me from FB friends unless I feel that person really wants/needs me to pay attention.
I hope it helps and that the word spreads.
I had also thanked you (and to mdudley too) for not giving up on this.
I usually ignore posts and polls that come to me from FB friends unless I feel that person really wants/needs me to pay attention.
I hope it helps and that the word spreads.
I had also thanked you (and to mdudley too) for not giving up on this.
You are reading content posted in the Hepatitis Social Community
A list of national and international resources and hotlines to help connect you to needed health and medical services.
Herpes sores blister, then burst, scab and heal.
Herpes spreads by oral, vaginal and anal sex.
STIs are the most common cause of genital sores.
Condoms are the most effective way to prevent HIV and STDs.
PrEP is used by people with high risk to prevent HIV infection.
